6th Scientific Summit: latest findings by CoEHAR presented in Athens
The findings presented by CoEHAR researchers can contribute the discussions of ENDS for cessation and support harm reduction strategies in the world.
Bari, Polosa: “Risk reduction to fight atherosclerosis”
“However, it is important to understand a fact when talking about smoking: even today, nicotine is believed to play a major role in the developing of atherosclerosis” explains prof. Polosa “Nicotine does not cause atherosclerosis. In a survey conducted by SERMO on 1000 Italian doctors, it was found that 62 percent of the sample still think that atherosclerosis is caused by nicotine. The fact that 33 percent of the sample is made up of cardiologists is significant".
Cochrane: Some medicines and e-cigarettes can help people to quit smoking
According the authors, for every 100 people, 10 to 19 are likely to quit using an e-cigarette; 12 to 16 using varenicline; and 10 to 18 using cytisine. This is compared to the 6 in 100 people likely to quit when using no medicine/e-cigarette or placebo. People using two forms of nicotine replacement therapy at the same time, for example, a combination of nicotine patch and nicotine gum, seemed to have similar rates of quitting to people using e-cigarettes, varenicline and cytisine.
Letter to the Editors of Substance Abuse: vaping and youths researches
According to prof. Riccardo Polosa, CoEHAR founder: "This small qualitative research simply found what we already knew: that young people are eager to explore new experiences, with vaping potentially being one of them. A critical limitation of this research is the absence of insights into how these participants have been educated about the health implications and addictive nature of nicotine/vaping. To work towards a smoke-free world, it's essential that our messaging on vaping's risk-to-benefit ratio is both accurate and truthful"
CoEHAR advocate for e-liquids regulation: first ever reported urticaria case associate with vaping
For the first time, CoEHAR researches reported a case of urticaria following the inhalation of a specific flavoring in an e-liquid used during a switching trial. Although linked to a specific component of the liquid used, this finding highlight the need of further regulation of e-liquid.
ENDS for smoking cessation: CoEHAR published the umbrella review protocol
"We decided to provide the widest overview of clinical evidence on smoking submission and quit rates and absitance rates of e-cigarettes to researchers and clinicians” explain dr. Renèe O’Leary, author of the protocol.
SRNT-E 2023: varenicline and vaping cessation at the London conference
On Monday 11 September, prof. Caponnetto has presented "Varenicline and counseling for vaping cessation: A double-blind, randomized, parallel-group, placebo-controlled trial".
Atherosclerosis and smoking: Polosa at the SISA national conference
The conference will bring together leading experts in the field to discuss the latest research on dyslipidemias and their management. Topics to be covered include the latest guidelines from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), as well as innovative topics such as environmental risk factors, including smoking, and their role in the progression of atherosclerosis.
6th Scientific Summit on THR – Athens
Prof. Giovanni Li Volti, director of CoEHAR e dr. Renèe O'Leary will be in conference as a speakers with two interesting abstract on Harm Reduction and CoEHAR research.
CoEHAR members raised concerns on South Africa drafted bill on smoking
"We read with interest the proposed draft bill and we are appreciative of the key contributions this Bill will make in relation to the contrast of tobacco smoking. However, we are concerned that the current draft will restrict less risky options for people who would benefit from using these products to quit smoking. Bringing regulatory parity between cigarettes and non-combustible alternatives (like e-cigarettes, heated tobacco products, oral nicotine/tobacco pouches) will further discourage smokers from trying alternatives – something that should be actively encouraged given that South Africa has high smoking prevalence and low successful quitting rate"
- Go to the previous page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- …
- 32
- Go to the next page
